TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 39 filers reported holding TRANSPHORM INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 4,619,558 | $10,255,419 | 4.85% |
| Kohlberg Kravis Roberts & Co. L.P. | 22,675,980 | $50,340,676 | 1.77% |
| Worth Venture Partners, LLC | 1,152,278 | $2,558,057 | 1.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 250,084 | $555,187 | 0.78% |
| Black Maple Capital Management LP | 63,923 | $141,909 | 0.10% |
| Taylor Frigon Capital Management LLC | 62,500 | $138,750 | 0.08% |
| Polar Asset Management Partners Inc. | 1,009,702 | $2,241,538 | 0.05% |
| Soros Fund Management | 340,000 | $754,800 | 0.01% |
| AMERIPRISE FINANCIAL INC | 4,443,329 | $9,864,191 | 0.00% |
| Stratos Wealth Partners, LTD. | 25,640 | $56,921 | 0.00% |